×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
CHALLENGES FOR DEVELOPMENT OF RARE DISEASES
Session Chair(s)
Peter W.L. Bogaert, MA
Partner
Covington & Burling LLP, Belgium
Registries for Rare Diseases
Learning Objective : • Understand the challenges of establishing a patient registry in an ultra-orphan disease area • Understand how incremental organizational steps can be taken to create the foundation for larger and richer registries
Speaker(s)
Strategic View of a Regulator on Effective Development of Therapies for Rare Diseases
Diederick Slijkerman, PhD, LLM
Medicines Evaluation Board, Netherlands
Head of Policy, Governance & Regulatory Affairs
Registries for Rare Diseases
Badri Rengarajan, MD
Jazz Pharmaceuticals, United States
Life Sciences
Experiences from Orphan Exclusivity in the EU
Peter W.L. Bogaert, MA
Covington & Burling LLP, Belgium
Partner
Have an account?